NEW YORK, Oct. 21 (GenomeWeb News) - Tata Consultancy Services of Mombai, India, and Israeli pharma BioStrx will co-develop lead drug compounds, the companies said last week.

 

The companies will collaborate on protein crystallization and structure determination to provide optimized lead compounds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.